EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

INFLUENZA VACCINE AND ITS EFFICACY

Ammar Ahmad

NORTHWEST JOURNAL OF MEDICAL SCIENCES · 2022

DOI: 10.69723/njms.01.04.0294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NORTHWEST JOURNAL OF MEDICAL SCIENCES, 2022. Verfasst von Ammar Ahmad. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza is one of the most common infection in the world. Alot of research has been invested into development of vaccines to counter it It is very contagious and it has overburdened our health systems during Influenza epidemics. It is estimated to bring socioeconomic cost of 87 billion USD per year globally. (1) If we develop equitable vaccine distribution model, we can lessen this burden by using only a fraction of the resources that we lose to Influenza every year. Based on earlier evidence, WHO suggested that any type of influenza vaccine is more effective than Placebo and it is recommended to do annual vaccination in high risk population(2). Recent evidence propose that efficacy changes with the type of vaccine used. Quadrivalent vaccines have higher efficacy than the placebos and monovalent vaccines. (3)

Zitieren

APA

Ahmad, A. (2022). INFLUENZA VACCINE AND ITS EFFICACY. NORTHWEST JOURNAL OF MEDICAL SCIENCES. https://doi.org/10.69723/njms.01.04.0294

Vancouver

Ahmad A. INFLUENZA VACCINE AND ITS EFFICACY. NORTHWEST JOURNAL OF MEDICAL SCIENCES. 2022. doi:10.69723/njms.01.04.0294

BibTeX
@article{Ahmad2022,
  author = {Ahmad, Ammar},
  title = {INFLUENZA VACCINE AND ITS EFFICACY},
  journal = {NORTHWEST JOURNAL OF MEDICAL SCIENCES},
  year = {2022},
  doi = {10.69723/njms.01.04.0294}
}
Kostenlos starten →